Laboratory Proficiency Testing Market By Product Type (Proficiency Testing (PT) Programs, External Quality Assessment (EQA) Programs, Reference & Control Materials, Data Management & Reporting Software, Training & Consulting Services), By Material Type (Serum, Urine, Microbial Cultures, DNA & RNA Extracts, Synthetic Controls, Environmental Matrices, Digital Images, Specialty Matrices), By Assessment Method (Quantitative PT, Qualitative PT, Semi-Quantitative, Accuracy-Based, Peer Group Comparison PT, Alternative PT, Inter-laboratory Comparisons), By Technology (Clinical Chemistry & Immunoassays, Hematology & Coagulation Testing, Molecular Diagnostics, Microbiology & Infectious Disease Testing, Chromatography & Mass Spectrometry, Histopathology, Point-of-Care Testing), By End User (Hospital & Clinical Laboratories, Reference Laboratories, Pharmaceutical & Biotech Companies, Food & Environmental Testing Laboratories, Academic & Research Institutions, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles And Market Forecast, 2025 – 2035.

---

What trends will shape the Laboratory Proficiency Testing Market in the coming years?

The Laboratory Proficiency Testing Market accounted for USD 1.51 Billion in 2024 and USD 1.61 Billion in 2025 is expected to reach USD 3.15 Billion by 2035, growing at a CAGR of around 6.90% between 2025 and 2035. The Laboratory Proficiency Testing (PT) Market is poised to grow exponentially as laboratories around the world are seeing increasingly stringent regulatory demands and rising pressure on accurate results. The growing use of molecular diagnostics, genomics, and next-generation sequencing will contribute to the need to increase the use of special PT schemes. Increasing application of chromatography and mass spectrometry in the testing of pharmaceuticals and food is coming up with more PT requirements.

Digital pathology and AI-based image analysis are becoming significant domains to test their expertise. Growth in point-of-care testing (POCT) will need PT programs specifically aligned to decentralized sites. More emphasis will increasingly be placed on tailor-made and precision-based PT measures to accommodate complicated assays. The expanse of food safety, environmental samples, and cannabis testing will expand the use of PT. There will be integration of cloud-based data reporting and analytics platforms, which will boost efficiency. The growing involvement of emerging economies, in particular in the Asia-Pacific, will drive the global growth. High priority on ISO/IEC 17043 accreditation and quality assurance will continue to be popular initiatives that drive the market.

What do industry experts say about the Laboratory Proficiency Testing market trends?

"The integration of AI and machine learning into proficiency testing is revolutionizing the industry. These technologies enhance accuracy, reduce human error, and enable real-time data analysis, ensuring laboratories meet the highest standards of quality assurance."

• Dr. Emily Johnson, CEO of BioProficiency Labs.

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Laboratory Proficiency Testing market?

How is the rising demand for accurate clinical diagnostics fueling the proficiency testing market expansion worldwide?

The Global Laboratory Proficiency Testing Market is growing at a very fast pace because of the increasing demand for adequate clinical diagnostics. In the U.S., clinical laboratory tests impact more than 70% of physician decision-making, which presents as a testimony of their importance in patient care. This ever-so-dependable use of precise diagnostics has tremendously brought about the necessity of proficiency testing programs so that laboratories can be both accurate and dependable. With the increasing prevalence of chronic diseases (cancer, diabetes, and cardiovascular diseases), the volume of diagnostic tests continues to mount, with the insistence on ensuring quality within laboratories. Through proficiency testing, mistakes are found and rectified, which makes the results have similar and accurate findings, regardless of the laboratory where they are carried out.

The new developments in diagnostic technologies, such as molecular diagnostics, next-generation sequencing, and AI-based diagnostic tools, must have new proficiency testing techniques to ensure accuracy. Stricter regulatory standards are being imposed by the regulatory bodies in any part of the world; this has made the use of proficiency testing as a compliance and accreditation measure in laboratories important. The working environment of automated analytics, with the assistance of digital reporting platforms, bestows further efficiency and test procedure workflow optimization. Increased adoption is also due to the growing awareness of medical practitioners regarding patient safety and the accuracy of diagnosis. In total, the growing demands of diagnosing, technology development, regulatory, and quality assurance requirements are driving growth in the Global Laboratory Proficiency Testing Market.

In what ways does stringent regulatory compliance enhance the adoption of external quality assessment programs?

The Global Laboratory Proficiency Testing Market is highly affected by regulatory requirements, as more than 36,000 laboratories in the U.S. must partake in CMS-approved proficiency testing schemes as part of CLIA regulations. This compulsory involvement secures the stability of the analytical precision and reliability of the laboratories, inciting a strong implementation of the external quality assessment programs. Compliance promotes investment in high-quality PT schemes, which improves the laboratory's credibility in operations and standards. It also harmonizes the testing conduct of different regions and reduces disparities in the results of the diagnosis.

Laboratories that conform to such laws are in a position to prove accountability and guarantees of quality to healthcare providers and patients. The increasingly higher quality standards encourage laboratories to improve techniques and introduce newer technologies on an ongoing basis in proficiency testing. Regulatory oversight leads to a culture of continuous improvement that minimizes mistakes and maximizes patient safety. It also builds confidence in laboratory outputs by clinicians and the public health control officers. Consequently, proficiency testing emerges as an indispensable measure in terms of high-quality diagnostics. In general, regulatory compliance is a major force behind the growth and sophistication of the global laboratory proficiency testing market.

What challenges do the high operational costs of PT programs impose on small laboratories globally?

Proficiency testing programs are expensive to run, and this poses a big challenge to small laboratories all over the world. The global laboratory proficiency testing market demands significant investments in participation fees, special materials, and repetitive sample dispatch, and it may be a business that can become financially burdensome. Smaller laboratories can find it challenging to justify the costs of expensive PT schemes, such as molecular diagnostics, microbiology, or digital reporting solutions. Cost may be a limiting factor towards access to full programs of external quality assessment, and hence the accuracy and consistency of results. Small facilities are also burdened with high training costs for the staff and the cost of software integration.

In the developing regions, laboratories incur further logistical expenditures, such as international freight and customs fees. Such financial constraints may cause a decrease in the rate of participation that slows down the detection of mistakes and the counteracting measures. The smaller labs can give priority to the routine testing at the expense of patient safety. However, the purchase of advanced technologies and AI-driven analytics is sometimes limited by the cost factor. Overall, the high cost of operation compromises the small laboratories' ability to remain compliant and accurate, and competitive in the Global Laboratory Proficiency Testing Market.

How can digital reporting platforms and AI-driven analytics optimize proficiency testing workflows efficiently?

Digital reporting platforms and AI-powered analytics are transforming the Global Laboratory Proficiency Testing Market by automating proficiency testing workflows in efficient ways. The technologies make data collection almost easier and minimize the chances of manual errors, and make the results of the test more accurate and reliable. With massive volumes of data, AI algorithms can uncover patterns and help identify abnormalities and make quicker and data-based decisions. Online platforms make real-time reporting and feedback available, which gives the laboratories an opportunity to solve discrepancies and hone the testing process in due time. Automating routine processes gives the personnel of the laboratory the chance to concentrate on complicated analyses and quality control procedures. Such innovations help to minimize the costs of operating and ensure that costly mistakes do not occur.

The use of digital and AI technology also provides an environment that meets the high regulatory standards by having a traceable testing process. Predictive analytics can also be integrated to enable a laboratory to pre-empt possible problems in quality before they occur in results. The cloud-based systems enable collaboration and benchmarking, which can be conducted across sites, and enhance the rate of effectiveness of the proficiency testing. Overall, these technologies improve efficiency, accuracy, data integrity, and compliance with regulations, as each aspect promotes growth and modernization of the global laboratory proficiency testing market.

In what ways does expanding point-of-care testing adoption create new PT service requirements?

The Global Laboratory Proficiency Testing Market is growing significantly because of the increased use of point-of-care testing (POCT) in the clinical area. The number of healthcare providers applying POCT is noticeably high, as 81% apply POCT, which is evidence of its popularity and the necessity to have specific proficiency testing services. Traditional PT programs that are optimized for centralized laboratory settings do not support the decentralized location and turnaround times of POCT processes. This creates a need to develop special PT programs to check the accuracy of devices, the competency of operators, and other environmental factors that might influence the results.

The connection of the digital reporting platform and AI-based analytical tools helps address an abundance of data created by POCT with real-time tracking and analytics. Regulatory authorities are setting up new standards to ensure there is uniformity and good quality across testing facilities, which are different. Psychosocial T services will have to change the way they assess a broader spectrum of devices, technologies, and clinical situations. This will enable patient safety to be assured since diagnostic accuracy will be maintained in all healthcare settings. Quality control measures and special training are also becoming essential to POCT operators. Generally, the expansion of POCT use is influencing the practice and complexity of the Global Laboratory Proficiency Testing Market.

What are the key market segments in the Laboratory Proficiency Testing industry?

Based on the product type, the Laboratory Proficiency Testing Market is classified into proficiency testing (PT) programs, external quality assessment (EQA) programs, reference & control materials, data management & reporting software, and training & consulting services. Laboratory Proficiency Testing the market, by byproduct type, is dominated by Proficiency Testing (PT) programs, which are the core service of providing laboratories with benchmarking performance versus industry peers. External Quality Assessment (EQA) schemes accompany PT programs and therefore offer a more comprehensive framework of evaluation, including regulatory compliance in many cases.

Control and reference materials are essential to standardization and calibration, and to the accuracy of results of various assays. Split-sample or alternative PT solutions can serve laboratories that lack a commercial PT panel and wish to develop a custom panel or niche testing panel. The use of data management and reporting platforms is on the rise and enables automatic submission of results, scoring, and analytics. There are training and consulting services in addition to core PT products to aid in corrective measures and optimization of methods. Overall, the product line is a balanced portfolio of recurring PT rounds, regulatory-based assessments, and technologically advanced solutions to accommodate increased laboratory needs.

Based on the technology, the Laboratory Proficiency Testing Market is classified into clinical chemistry & immunoassays, hematology & coagulation testing, molecular diagnostics, microbiology & infectious disease testing, chromatography & mass spectrometry, histopathology, and point-of-care testing. By technology, the laboratory proficiency testing market is led by highly utilized clinical chemistry and immunoassays, both of which are the driving markets in terms of widespread diagnostics application and active engagement in the PT market. Molecular diagnosis (PCR, qPCR, and NGS) is a fast-growing procedure with growing numbers in personalized medicine, and due to the increasing testing of infectious diseases. Coagulation, PT, and hematology are still vital in the proper analysis of blood and the safety of the patient. Infectious disease and microbiology testing are growing, especially as antimicrobial resistance surveillance increases in popularity.

The pharmaceutical, food, and environmental laboratory systems are dependent on chromatography and mass spectrometry (HPLC, GC-MS, LC-MS/MS) and have more distinctive PT requirements. Digital pathology, manipulated imaging and scanning, along with knowledge in pathology and cytology, are fields that AI-driven scoring and virtual slides pave the path to support. Also, there is an interest in point-of-care testing (POCT) devices, which conforms to the tendency of decentralized and fast diagnostics.

Which regions are leading the Laboratory Proficiency Testing market, and why?

The North America Laboratory Proficiency Testing Market is leading due to the intense regulatory systems like CLIA and the use of ISO/IEC 17043-accredited programs of proficiency testing. The area contains numerous top PT providers such as CAP, Bio-Rad, and Eurofins, which possess a wide range of services in clinical, pharmaceutical, and environmental markets. The demand for specialized PT schemes is driven by high investment in highly sophisticated technologies in the field of diagnostics, like molecular diagnostics, NGS, and mass spectrometry.

A digital platform integrated with AI-based data analytics can increase efficiency and real-time reporting of the laboratory, and remote access. The quality assurance and accreditation of laboratories are also of concern in North America, which increases the repeated PT subscriptions. Point-of-care and decentralized testing also contribute to expansion in the market. They are also complemented by partnerships with other hospitals, research, and public health agencies that facilitate adoption in numerous applications. In sum, the area is a fusion of regulation, technology, and provider savoir faire and therefore a global aggregate force in terms of market dynamics.

The Asia Pacific Laboratory Proficiency Testing Market is growing due to the speedy growth of clinical diagnostics, pharmaceuticals, and food testing labs. PT adoption is being supported by growing government efforts to be regulatory compliant and lab accreditation in emerging economies such as China, India, and Southeast Asia. The increase in incidence of infectious diseases and chronic disorders is enhancing the market demand for molecular diagnostics, immunoassays, and specialty PT programs. There are robust investments in the modern laboratory infrastructure and emerging technologies like NGS, digital pathology, and mass spectrometry in the region.

The market is experiencing market uptake due to awareness regarding the quality assurance and safety among healthcare providers. The growth of privately owned networks of diagnosis and independent laboratories is raising the possibility of uniform PT schemes. Cloud-based analytics and digital reporting platforms are gaining acceptance to automate inter-laboratory comparisons. At present, the growth of the healthcare market in Asia-Pacific is unprecedented due to the presence of rapid development of the medical sector, and regulatory and technological adoption.

What does the competitive landscape of the Laboratory Proficiency Testing market look like?

The competitors in the Laboratory Proficiency Testing Market are numerous, and the industry is highly competitive, as the key players, such as Bio-Rad Laboratories, LGC Limited, INSTAND, and AOAC INTERNATIONAL, control the industry. The various PT programs offered by these companies are designed to ascertain laboratory accuracy, regulatory compliance, and quality assurance of the clinical, pharmaceutical, food, and environmental fields. Competition is fuelled by innovation in digital reporting platforms, AI-based analytics, and specific PT schemes to promote molecular diagnostics, pathology, and mass spectrometry. To provide a differentiated solution, providers are emphasizing their training services and those that are customized.

The strategic expansions, partnerships, and acquisitions are widely used to complement regional presence and service portfolios. Another trend in the market is related to cloud-based and distance participation in PT, which also increases accessibility in laboratories around the world. The rising adoption in new markets such as the Asia-Pacific is driving the growth and competition. Growth in R&D by companies to enable individualized assays and new types of diagnostics. Regulatory compliance, quality assurance, and accreditation supportive services are other value propositions. In the recent past, Bio-Rad Laboratories increased its coverage in Asia PT products to meet the rising demand of laboratory accreditation and quality assurance programs as an indication of the dynamism of the competitive environment.

Laboratory Proficiency Testing Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Laboratory Proficiency Testing industry?

• In August 2025, Bio-Rad Laboratories launched its Unity Next Peer QC data management software in the Asia-Pacific region. This software aims to enhance the troubleshooting of quality control errors and bolster confidence in patient testing results. It provides laboratories with on-demand access to peer reporting, quality control data, and tools for data visualization and report generation, supporting compliance management. 

Report Coverage:

By Product Type

• Proficiency Testing (PT) Programs
• External Quality Assessment (EQA) Programs
• Reference & Control Materials
• Data Management & Reporting Software
• Training & Consulting Services

By Material Type

• Serum
• Microbial Cultures
• DNA & RNA Extracts 
• Synthetic Controls
• Environmental Matrices
• Digital Images
• Specialty Matrices

By Assessment Method

• Quantitative PT
• Qualitative PT
• Semi-Quantitative
• Accuracy-Based
• Peer Group Comparison PT
• Alternative PT
• Inter-laboratory Comparisons

By Technology

• Clinical Chemistry & Immunoassays
• Hematology & Coagulation Testing
• Molecular Diagnostics
• Microbiology & Infectious Disease Testing
• Chromatography & Mass Spectrometry
• Histopathology
• Point-of-Care Testing

By End User

• Hospital & Clinical Laboratories
• Reference Laboratories
• Pharmaceutical & Biotech Companies
• Food & Environmental Testing Laboratories
• Academic & Research Institutions
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Bio-Rad Laboratories, Inc.
• LGC Limited
• INSTAND e.V.
• AOAC INTERNATIONAL
• Eurofins Scientific SE
• Quality Control for Molecular Diagnostics
• College of American Pathologists (CAP)
• Thermo Fisher Scientific Inc.
• Roche Diagnostics International Ltd.
• Siemens Healthineers AG
• Abbott Laboratories
• Mindray Medical International Limited
• Sysmex Corporation
• PathoCheck Diagnostics, Inc.
• Oncocyte Corporation

Frequently Asked Questions (FAQs)